Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus

NCT00010413 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Pemphigus

Interventions

DRUG: cyclophosphamide
DRUG: filgrastim

Sponsor

Johns Hopkins University